SPK-9001 MANUFACTURE AND SUPPLY AGREEMENTManufacturing Agreement • May 8th, 2018 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances)
This SPK-9001 MANUFACTURE AND SUPPLY AGREEMENT (this “Agreement”) is made as of February 16, 2018 (the “Effective Date”), by and between Pfizer Inc., a corporation organized and existing under the laws of the State of Delaware, with offices at 235 East 42nd Street, New York, New York 10017 (“Customer”), Spark Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware, with offices at 3737 Market Street, Suite 1300, Philadelphia, Pennsylvania 19104 (“Supplier”). Customer and Supplier may be referred to herein individually as a “Party” and collectively as the “Parties”.
